Literature DB >> 28374339

Structure-Function Analysis of Phenylpiperazine Derivatives as Intestinal Permeation Enhancers.

Katherine C Fein1, Nicholas G Lamson1, Kathryn A Whitehead2,3.   

Abstract

PURPOSE: A major obstacle preventing oral administration of macromolecular therapeutics is poor absorption across the intestinal epithelium into the bloodstream. One strategy to improve transport across this barrier is the use of chemical permeation enhancers. Several molecular families with permeation enhancing potential have been identified previously, including piperazines. In particular, 1-phenylpiperazine has been shown to enhance transepithelial transport with minimal cytotoxicity compared to similarly effective molecules. To better understand how the chemistry of 1-phenylpiperazine affects its utility as an intestinal permeation enhancer, this study examined a small library of 13 derivatives of 1-phenylpiperazine.
METHODS: The efficacy and cytotoxicity of 13 phenylpiperazine compounds were assessed in a Caco-2 model of the intestinal epithelium. Efficacy was measured using the paracellular diffusion marker calcein as well as by immunostaining and confocal imaging of Caco-2 monolayers.
RESULTS: Of the 13 derivatives, two enhanced the permeability of the fluorescent marker calcein over 100-fold. It was found that hydroxyl or primary amine substitutions on the phenyl ring significantly increased toxicity, while aliphatic substitutions resulted in efficacy and toxicity profiles comparable to 1-phenylpiperazine.
CONCLUSIONS: Several potent derivatives, including 1-methyl-4-phenylpiperazine and 1-(4-methylphenyl)piperazine, displayed lower toxicity than 1-phenylpiperazine, suggesting promise in future applications.

Entities:  

Keywords:  1-phenylpiperazine; Caco-2; oral delivery; permeation enhancer; piperazine derivatives

Mesh:

Substances:

Year:  2017        PMID: 28374339     DOI: 10.1007/s11095-017-2149-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Oral delivery of macromolecules using intestinal patches: applications for insulin delivery.

Authors:  Kathryn Whitehead; Zancong Shen; Samir Mitragotri
Journal:  J Control Release       Date:  2004-07-23       Impact factor: 9.776

Review 2.  Oral delivery of macromolecular drugs: Where we are after almost 100years of attempts.

Authors:  Elena Moroz; Simon Matoori; Jean-Christophe Leroux
Journal:  Adv Drug Deliv Rev       Date:  2016-01-27       Impact factor: 15.470

3.  Safe and effective permeation enhancers for oral drug delivery.

Authors:  Kathryn Whitehead; Natalie Karr; Samir Mitragotri
Journal:  Pharm Res       Date:  2007-12-05       Impact factor: 4.200

4.  Sustained gastrointestinal activity of dendronized polymer-enzyme conjugates.

Authors:  Gregor Fuhrmann; Andrea Grotzky; Ružica Lukić; Simon Matoori; Paola Luciani; Hao Yu; Baozhong Zhang; Peter Walde; A Dieter Schlüter; Marc A Gauthier; Jean-Christophe Leroux
Journal:  Nat Chem       Date:  2013-06-09       Impact factor: 24.427

5.  An Assessment of the Permeation Enhancer, 1-phenyl-piperazine (PPZ), on Paracellular Flux Across Rat Intestinal Mucosae in Ussing Chambers.

Authors:  V A Bzik; D J Brayden
Journal:  Pharm Res       Date:  2016-07-07       Impact factor: 4.200

6.  Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery.

Authors:  Eric M Pridgen; Frank Alexis; Timothy T Kuo; Etgar Levy-Nissenbaum; Rohit Karnik; Richard S Blumberg; Robert Langer; Omid C Farokhzad
Journal:  Sci Transl Med       Date:  2013-11-27       Impact factor: 17.956

7.  The pH of Piperazine Derivative Solutions Predicts Their Utility as Transepithelial Permeation Enhancers.

Authors:  Nicholas G Lamson; Gabrielle Cusimano; Kanika Suri; Anna Zhang; Kathryn A Whitehead
Journal:  Mol Pharm       Date:  2016-01-13       Impact factor: 4.939

8.  In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix.

Authors:  Davide Guggi; Constantia E Kast; Andreas Bernkop-Schnürch
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

9.  Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.

Authors:  Vivek Gupta; Byeong Hee Hwang; Joohee Lee; Aaron C Anselmo; Nishit Doshi; Samir Mitragotri
Journal:  J Control Release       Date:  2013-09-11       Impact factor: 9.776

10.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.

Authors:  P Artursson
Journal:  J Pharm Sci       Date:  1990-06       Impact factor: 3.534

View more
  3 in total

1.  Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.

Authors:  V Stuettgen; D J Brayden
Journal:  AAPS J       Date:  2020-01-27       Impact factor: 4.009

2.  Thrifty, Rapid Intestinal Monolayers (TRIM) Using Caco-2 Epithelial Cells for Oral Drug Delivery Experiments.

Authors:  Nicholas G Lamson; Rebecca L Ball; Katherine C Fein; Kathryn A Whitehead
Journal:  Pharm Res       Date:  2019-10-28       Impact factor: 4.200

3.  The strawberry-derived permeation enhancer pelargonidin enables oral protein delivery.

Authors:  Nicholas G Lamson; Katherine C Fein; John P Gleeson; Alexandra N Newby; Sijie Xian; Kyle Cochran; Namit Chaudhary; Jilian R Melamed; Rebecca L Ball; Kanika Suri; Vishal Ahuja; Anna Zhang; Adrian Berger; Dmytro Kolodieznyi; Brigitte F Schmidt; Gloria L Silva; Kathryn A Whitehead
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-09       Impact factor: 12.779

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.